ArticleInternational journal of molecular sciences2022

Effects of Long-Term Temozolomide Treatment on Glioblastoma and Astrocytoma WHO Grade 4 Stem-like Cells.

Jonas Feldheim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.